Telithromycin: the first of the ketolides. - Wikidata - awgldk - TriplyDB

Telithromycin: the first of the ketolides.

Telithromycin: the first of the ketolides.

http://www.wikidata.org/entity/Q34564295

about

Structural Insight into the Antibiotic Action of Telithromycin against Resistant Mutants Telithromycin-induced digoxin toxicity and electrocardiographic changes.Telithromycin: a novel agent for the treatment of community-acquired upper respiratory infections Ketolides: an emerging treatment for macrolide-resistant respiratory infections, focusing on S. pneumoniae.Involvement of the drug transporters p glycoprotein and multidrug resistance-associated protein Mrp2 in telithromycin transport Pharmacokinetics of solithromycin (CEM-101) after single or multiple oral doses and effects of food on single-dose bioavailability in healthy adult subjects.Novel antibacterial agents for the treatment of serious Gram-positive infections.Do preclinical testing strategies help predict human hepatotoxic potentials?In vitro activities of novel 2-fluoro-naphthyridine-containing ketolides Effect of efflux on telithromycin and macrolide susceptibility in Haemophilus influenzae.Potential interaction between telithromycin and warfarin.Verapamil toxicity resulting from a probable interaction with telithromycin.

P2860

Q27641602-16ED3F83-4FFF-46BD-A25E-18AFC59D038E Q33153871-E84E129E-C9E1-427E-BE4A-83046A003F64 Q33945038-7CDC312F-491B-4C39-BB64-426AE2163B65 Q34281970-869A383B-321C-4832-BBE1-9228B182F76A Q34301527-0E2F5B0D-D4FC-4A92-A1C9-1BD270ED4E7C Q34932518-10CFEE6C-D1E5-400D-AFC1-099A902C47CE Q35073345-93C2E0D0-AAAD-401A-9640-77BD6468E327 Q36086429-DF531327-5851-4789-98F5-45052B2222A2 Q40733036-AEA5254D-1E22-4E53-98BB-1FF969E9AD76 Q41869629-BC03EA59-9BBC-461F-8DA5-56590DC65607 Q44997758-66EB7533-EA99-4371-8B5E-171F80C6DF61 Q45187291-2C509472-9CD9-49EB-9E0D-C21494CADA70

P2860

Telithromycin: the first of the ketolides.

http://www.wikidata.org/entity/Q34564295

description

2002 nî lūn-bûn

@nan

2002 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի մարտին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Telithromycin: the first of the ketolides.

@ast

Telithromycin: the first of the ketolides.

@en

Telithromycin: the first of the ketolides.

@nl

type

label

Telithromycin: the first of the ketolides.

@ast

Telithromycin: the first of the ketolides.

@en

Telithromycin: the first of the ketolides.

@nl

prefLabel

Telithromycin: the first of the ketolides.

@ast

Telithromycin: the first of the ketolides.

@en

Telithromycin: the first of the ketolides.

@nl

P1433

Q34564295-80FC3F25-60C4-4D82-BC7C-82A65AAF8313

P1476

Q34564295-938CE7FA-2F0B-4E98-8903-1A80D180A079

P2093

Q34564295-08984067-83BC-4751-9C28-499B6CC4D0AE

Q34564295-99C05BED-E9A7-454C-8D8C-D7D98BC607D7

P2860

Q34564295-0051E035-000E-4ED2-98DC-160DDB01CED0

Q34564295-0E3DF6DE-BDD6-46AD-A07E-2EF29F19386B

Q34564295-137FC19A-6C7A-4547-B2BE-AC4E934D5EB7

Q34564295-15DE6C96-881E-4690-A44B-EED0736AAA1E

Q34564295-166C7321-83C1-4926-B241-D1B0D76B8605

Q34564295-1F3A1F2C-FFC5-4A2E-AEE4-AD35B8C5003A

Q34564295-20B490AA-DF99-4870-9334-153A9B406727

Q34564295-38766079-05AD-4DB8-BE4D-32ED5A01D268

Q34564295-55B5E05D-AC39-4161-9BA1-F2CC7E96A58C

Q34564295-6B98A263-8FA6-4B71-9626-5416F1CC71D2

P304

Q34564295-CA77C402-84C5-4408-B0BD-87EDC0A56F08

P31

Q34564295-5A403FEB-6CC0-4270-BCBB-C901FE2F0100

P356

Q34564295-457B5CC5-9D8D-453A-9A66-4A22353225A5

P407

Q34564295-279050A2-1A96-4D3D-B089-24520C489389

P433

Q34564295-102F965E-D049-4DE0-BDCE-13E76381B4E4

P478

Q34564295-3FE737E5-8C92-411D-BC27-5EB1F2E132C1

P577

Q34564295-9052DB5A-43B2-47D9-9324-EC64F755250D

P698

Q34564295-27BFBD2C-514F-4FF2-8566-30967A978A5C

P356

P1433

Annals of Pharmacotherapy

P1476

Telithromycin: the first of the ketolides.

@en

P2093

Christopher S Shain

http://www.w3.org/2001/XMLSchema#string

Guy W Amsden

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro susceptibilities of rapidly growing mycobacteria to telithromycin (HMR 3647) and seven other antimicrobials

In vitro activities of the ketolides telithromycin (HMR 3647) and HMR 3004 compared to those of clarithromycin against slowly growing mycobacteria at pHs 6.8 and 7.4

Activities of antimicrobial agents against intracellular pneumococci

Synthesis and antibacterial activity of HMR 3647 a new ketolide highly potent against erythromycin-resistant and susceptible pathogens.

Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States.

In vitro development of resistance to telithromycin (HMR 3647), four macrolides, clindamycin, and pristinamycin in Streptococcus pneumoniae

In vitro activities of telithromycin (HMR 3647) against Rickettsia rickettsii, Rickettsia conorii, Rickettsia africae, Rickettsia typhi, Rickettsia prowazekii, Coxiella burnetii, Bartonella henselae, Bartonella quintana, Bartonella bacilliformis, an

Postantibiotic suppression of growth of erythromycin A-susceptible and -resistant gram-positive bacteria by the ketolides telithromycin (HMR 3647) and HMR 3004

Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage.

New research in macrolides and ketolides since 1997.

P304

452-464

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1345/APH.1A038

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2002-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11895060

http://www.w3.org/2001/XMLSchema#string